A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/46 (2006.01) A61K 48/00 (2006.01) A61P 9/10 (2006.01) C12N 9/20 (2006.01) C12N 15/63 (2006.01)
Patent
CA 2370081
The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such proteins, for the treatment of conditions including LPL responsive conditions, such as cardiovascular disease, hypertension, LPL deficiency, high triglyceride levels, low HDL-cholesterol levels or atherosclerosis.
La présente invention concerne l'utilisation d'un traitement obtenu à partir d'une protéine lipoprotéine lipase tronquée (LPL S447X), ainsi que des acides nucléiques codant ces protéines, destiné au traitement des états tels que les états sensibles à la LPL, comme par exemple les maladies cardio-vasculaires, l'hypertension, les carences en LPL, des taux de triglycérides élevés, des taux de cholestérol HDL faibles ou l'athérosclérose.
Excoffon Katherine Julie Diane Ashbourne
Hayden Michael R.
Kastelein John J. P.
Academic Hospital At The University Of Amsterdam
Amsterdam Molecular Therapeutics B.v. (amt)
Smart & Biggar
The University Of British Columbia
LandOfFree
Lipoprotein lipase (lpl) variant therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipoprotein lipase (lpl) variant therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipoprotein lipase (lpl) variant therapeutics will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1976386